HQYHealthEquity, Inc.

$92.62-1.2% 1Y

$92.62

$73.2152 weeks$106.83

HQY in its own filings

Nothing in HQY's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.

242

Events found in the filings · across 1,215 filings · the record starts in 2014

Hard flags: none
Hard flags
Most recent filing: Sep 30, 2026
Most recent filing · Form 8-K
Record starts: May 1, 2014
Record starts · the earliest filing Ryufin holds for this name

Details›

Next results filingsame week as a year ago: expected around Dec 2, 2026
SEC comment-letter activity19 occurrences: 2026-02-05

SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.

What the company said

The company's own words from its current reports to the SEC, newest first

Sep 30, 2026On September 24, 2026, the Board of Directors (the “Board”) of HealthEquity, Inc. (the “Company”) appointed Noémie Heuland as a member of the Board, effective immediately.Director or officer change · Form 8-K
May 8, 2026On May 5, 2026, each of Scott Cutler (President and Chief Executive Officer), James Lucania (Executive Vice President and Chief Financial Officer), Dr. Stephen Neeleman, M.D. (Founder and Vice Chairman), Michael Fiore (Executive Vice President and Chief Commercial Officer), Sunil Rajasekar (Executive Vice President …Director or officer change · Form 8-K
Apr 6, 2026On April 6, 2026, HealthEquity, Inc. (the “Company”) announced that the employment of Eli Rosner, the Company’s Chief Technology Officer, will be terminated by the Company without cause, effective April 17, 2026.Director or officer change · Form 8-K
Mar 30, 2026On March 26, 2026, the Board of Directors (the “Board”) of HealthEquity, Inc. (the “Company”) announced the appointment of William Gassen as a member of the Board, effective immediately.Director or officer change · Form 8-K